Table 2.
Association of registration characteristics with willingness to consider ECD offers, among all registrants during the study period (columns 2–3), those predicted to benefit from ECD kidneys according to the Merion algorithm (columns 4–5) and registrants aged 65 or over (columns 6–7). Relative rates (RR) and p-values from generalized linear models are shown.
All registrants | ECD-Benefit | Age ≥ 65 | ||||
---|---|---|---|---|---|---|
RR (95% CI) | p-Value | RR (95% CI) | p-Value | RR (95% CI) | p-Value | |
Age category: | ||||||
18– 39 years | Reference | |||||
40–49 years | 1.41 (1.30–1.53) | <0.001 | Reference | |||
50–59 years | 1.87 (1.62–2.15) | <0.001 | 1.34 (1.22–1.47) | <0.001 | ||
60–69 years | 2.37 (1.98–2.83) | <0.001 | 1.70 (1.47–1.96) | <0.001 | Reference | |
70–99 years | 2.67 (2.18–3.27) | <0.001 | 1.89 (1.58–2.26) | <0.001 | 1.07 (1.03–1.12) | <0.001 |
Sex: | ||||||
Male | 1.05 (1.02–1.07) | <0.001 | 1.06 (1.03–1.09) | <0.001 | 1.06 (1.03–1.09) | <0.001 |
Race: | ||||||
White | Reference | Reference | Reference | |||
Black | 1.10 (1.02–1.18) | 0.012 | 1.09 (1.02–1.17) | 0.011 | 1.01 (0.96–1.08) | 0.6 |
Hispanic | 1.02 (0.86–1.20) | 0.8 | 1.03 (0.86–1.23) | 0.7 | 0.98 (0.88–1.09) | 0.7 |
Asian | 0.88 (0.75–1.05) | 0.2 | 0.85 (0.71–1.03) | 0.1 | 0.85 (0.74–0.97) | 0.02 |
Body Mass Index | ||||||
>35 | 1.00 (0.95–1.05) | 0.9 | 0.98 (0.93–1.03) | 0.4 | 0.96 (0.92–1.00) | 0.1 |
Diagnosis: | ||||||
GN | 0.90 (0.83–0.97) | 0.009 | 0.83 (0.74–0.94) | 0.003 | 0.93 (0.88–1.00) | 0.042 |
PKD | 0.95 (0.89–1.01) | 0.1 | 0.88 (0.80–0.97) | 0.011 | 0.96 (0.91–1.01) | 0.1 |
DM | 1.02 (0.94–1.10) | 0.7 | 0.95 (0.84–1.08) | 0.4 | 0.96 (0.90–1.03) | 0.2 |
HTN | 0.98 (0.90–1.06) | 0.6 | 0.93 (0.84–1.04) | 0.2 | 0.97 (0.92–1.01) | 0.2 |
PRA: | ||||||
0–19% | Reference | Reference | Reference | |||
20–79% | 1.06 (0.99–1.12) | 0.1 | 1.05 (0.98–1.12) | 0.2 | 1.05 (1.00–1.10) | 0.1 |
80–100% | 1.11 (1.03–1.19) | 0.004 | 1.07 (0.99–1.15) | 0.1 | 1.06 (1.00–1.12) | 0.1 |
Insurance: | ||||||
Private | Reference | Reference | Reference | |||
Medicare | 1.13 (1.05–1.22) | 0.001 | 1.15 (1.06–1.26) | 0.001 | 1.15 (1.01–1.30) | 0.032 |
Medicaid | 0.98 (0.88–1.10) | 0.8 | 1.05 (0.94–1.17) | 0.4 | 1.10 (0.99–1.22) | 0.1 |
Center waiting time: | ||||||
0–749 days | Reference | Reference | Reference | |||
750–1349 | 0.93 (0.71–1.21) | 0.6 | 0.92 (0.75–1.12) | 0.4 | 0.96 (0.84–1.11) | 0.6 |
1350–1999 | 0.83 (0.61–1.12) | 0.2 | 0.85 (0.67–1.07) | 0.2 | 0.96 (0.83–1.12) | 0.6 |
2000–9999 | 0.76 (0.51–1.11) | 0.2 | 0.74 (0.53–1.04) | 0.1 | 0.78 (0.57–1.07) | 0.1 |
Center volume: | ||||||
0–299 | Reference | Reference | Reference | |||
300–499 | 1.06 (0.84–1.35) | 0.6 | 0.89 (0.71–1.13) | 0.3 | 0.94 (0.82–1.08) | 0.4 |
500–999 | 1.28 (1.02–1.60) | 0.031 | 1.18 (0.96–1.44) | 0.1 | 1.05 (0.92–1.20) | 0.5 |
Over 1000 | 1.07 (0.81–1.41) | 0.6 | 0.96 (0.72–1.26) | 0.7 | 0.98 (0.82–1.18) | 0.9 |